FUNDC1 and diabetic cardiomyopathy: Studies has revealed that high glucose-induced AMPK inhibition contributes to the onset of diabetic cardiomyopathy by upregulation of FUNDC1, FUNDC1-governed MAMs, and rises in mitochondrial Ca2+ in the heart.